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Background: Testing for cerebrospinal fluid (CSF)-restricted oligoclonal bands (OCB) by isoelectric focusing is used
to detect intrathecally produced total IgG. By contrast, antibody indices (AI) are assessed to test for intrathecally
produced antigen-specific IgG. A number of previous cases reports have suggested that AI testing might be more
sensitive than OCB testing in detecting intrathecal IgG synthesis.
Findings: Here we report on 21 patients with positive AI for either herpes simplex virus, varicella zoster virus,
cytomegalovirus, measles virus, rubella virus, or Borrelia burgdorferi in the absence of total-IgG OCB and,
accordingly, in the presence of a normal total-IgG CSF/serum ratio.
Conclusion: Our findings indicate that AI testing should not generally be omitted in OCB-negative patients and
provide a rationale for systematic and prospective studies on the comparative sensitivity and specificity of AI and
total-IgG OCB testing in infectious and other diseases of the CNS.
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reactionIntroduction
Testing for cerebrospinal fluid (CSF)-restricted total IgG
oligoclonal bands (OCB) by isoelectric focusing is a
highly sensitive method for detecting intrathecal IgG
synthesis, but does not take into account antibody speci-
ficity. By contrast, antibody indices (AI) are assessed to
test for antigen-specific intrathecal IgG synthesis [1]. It
is unclear whether AI assessment is useful in OCB nega-
tive patients. Currently, clinicians often do not test for
virus- or bacterium-specific AIs on cost grounds if evi-
dence for intrathecal total IgG synthesis as detected by
OCB testing is missing.
Back in 1992, however, Felgenhauer and Reiber reported
a positive varicella zoster virus (VZV)-specific AI in 6
total-IgG OCB-negative patients with VZV ganglionitis as
well as in 4 total-IgG OCB-negative patients with VZV* Correspondence: sven.jarius@med.uni-heidelberg.de
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reproduction in any medium, provided the ormeningitis, suggesting that AI calculation might be more
sensitive than total-IgG OCB testing [2]. Here, we report
on 21 total-IgG OCB-negative patients with positive AI
results for either herpes simplex virus (HSV), VZV, cyto-
megalovirus (CMV), measles virus (MV), rubella virus
(RV), or Borrelia burgdorferi (Bb), thereby providing inde-
pendent and corroborative evidence for Felgenhauer and
Reiber’s hypothesis (see Table 1 for details).
Methods and results
Testing for OCB was performed by a CSF laboratory
with long-standing expertise in the field that takes part
in the official German external quality assessment orga-
nized by INSTAND e.V. twice a year. OCB were deter-
mined by isoelectric focusing followed by anti-IgG
immunofixation (Sebia, Fulda, Germany). Serum and
CSF levels of antibodies to HSV, VZV, CMV, MV, RV,
and Bb were assessed using commercially available en-
zyme linked immunosorbent assays (Enzygnost, Siemes
Healthcare, Eschborn, Germany). Total-IgG and total al-
bumin concentrations in CSF and serum weretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Patient data and antibody indices to six viral antigens in CSF samples negative for total-IgG oligoclonal bands














Suspected diagnosis and indicated by the sender
#1A 32 M NEG/NEG Not det. 0.72 0.74 Not det. 0.69 0.77 1557 CSF PCR positive HSV encephalitis
#1B 32 M NEG/NEG Not det. 43.40 1.24 Not det. ND ND 1456 CSF PCR positive HSV encephalitis, follow-up 19 days later
#1C 32 M NEG/NEG ND 53.40 16.30# ND ND ND 152 CSF PCR positive HSV encephalitis, follow-up a further 3 days later
#2A 33 M NEG/NEG Not det. 2.02 1.54 ND ND 0.83 No data Blistering rash V2, peripheral facialis paresis
#2B 33 M NEG/NEG ND 1.94 1.39 ND ND ND 19 Blistering rash V2, peripheral facialis paresis, follow-up 8 days later
#3 30 M NEG/NEG ND 2.43 1.12 ND 0.85 1.10 2 No data available
#4 29 F NEG/NEG Not det. 2.12 0.99 1.30 ND 0.94 3 No data available
#5A 34 F NEG/NEG Not det. ND ND ND ND ND No data VZV meningoencephalitis
#5B 34 F NEG/NEG ND Not det. 3.99 Not det. ND ND 360 VZV meningoencephalitis, follow-up 5 days later
#6 60 F NEG/NEG Not det. 1.20 2.40 0.86 ND ND 2 “FK506-associated leukoencephalopathy”, grand mal
#7 51 M NEG/NEG 1.26 1.11 2.42 1.03 0.90 1.03 1 “Fatigue and apathy”
#8 42 M NEG/NEG Not det. 1.31 3.26 ND 1.03 1.32 3 “Possible multiple sclerosis“
#9 74 F NEG/NEG ND 1.43 2.30 Not det. ND 0.81 2 No data available
#10 50 F NEG/NEG ND Not det. 2.00 ND 0.85 0.67 No data No data available
#11 71 F POS/POS* 20.90 1.45 1.32 Not det. 0.97 0.91 4 Neuroborreliosis, encephalitis
#12A 34 F NEG/NEG 2.60 0.91 0.80 Not det. 0.70 0.80 82 Neuroborreliosis with abducens and facial nerve paresis
#12B 34 F NEG/NEG 1.70 0.91 0.95 Not det. 1.15 0.83 277 Confirmatory follow-up sample obtained 5 days later
#13 44 M NEG/NEG 10.60 0.90 1.00 0.88 1.5 ND No data "Aseptic Meningitis”
#14 84 M NEG/NEG 5.31 1.02 0.99 0.85 1.02 1.04 2 No data available
#15 34 F NEG/NEG 4.79 Not det. 0.99 Not det. 0.92 ND 1 No data available
#16 57 M NEG/NEG 3.30 0.96 0.88 1.20 0.76 0.75 1 No data available
#17 21 M NEG/NEG 2.50 Not det. 0.85 Not det. ND 0.85 1 No data available
#18 38 F NEG/NEG ND 1.67 1.00 2.40 0.44 0.94 No data “Encephalitis”
#19 40 F NEG/NEG Not det. Not det. 16.20 1.43 0.72 0.90 No data No data available
#20 25 F NEG/NEG Not det. 0.92 1.00 Not det. ND 2.10 1 “Clinically possible multiple sclerosis (Poser)”
#21 60 M NEG/NEG ND 0.85 0.87 Not det. 2.80 0.92 No data No data available
AI = antibody index; Bb = Borrelia burgdorferi; CMV= cytomegalovirus; HSV = herpes simplex virus; MV=measles virus; NEG/NEG= negative in CSF/negative in
serum; not det. = not detectable; ND=not done; OCBs = oligoclonal bands; RV = rubella virus; VZV = varicella zoster virus. * Mirror pattern (so-called “pattern 4”
according to an international consensus on OCB diagnostics) in the absence of CSF-restricted IgG bands. # Cross-reactivity between HSV and VZV as a result of
epitope spreading (see reference [2]).
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ing, Germany). Intrathecal synthesis of IgG to HSV,
VZV, CMV, MV, RV, and Bb was determined by calculat-
ing the respective antibody indices (AI): AI=QIgG[spec]/
QIgG[total], if QIgG[total]<Qlim, and AI=QIgG[spec]/
Qlim, if QIgG[total]>Qlim, with QIgG[spec]=IgGspec
[CSF]/IgGspec[serum], and QIgG[total]=IgGtotal[CSF]/
IgGtotal[serum][1,3]. The upper reference range of
QIgG[total], Qlim, was calculated according to Reiber’s
formula [1]. No lumbar puncture or phlebotomy was
performed for this study, and no stored CSF or serum
samples were used for this study. Instead, all data were
retrieved retrospectively by an automated database
search and analyzed anonymously. As clinical data were
not available from all patients due to anonymization, a
very conservative cut-off for AI positivity (2.0 instead of1.3) was applied to preclude false-positive results. No
other inclusion and exclusion criteria than OCB negativ-
ity and presence of a positive AI for any of those six viral
and bacterial antigens in the same paired CSF/serum
sample were applied. A positive AI was present for Bb in
7 cases (2.5-20.9; median, 4.794) for HSV in 4 cases
(2.02-43.4; 2.28), for VZV in 7 (2–16.2; 2.42), for CMV
in 1 (2.40), for MV in 1 (2.80), and for RV in 1 (2.10). In
case #1, HSV encephalitis was confirmed by PCR and a
follow-up lumbar puncture (LP) confirmed the positive
AI, again in the absence of total-IgG OCB. In a second
case with positive HSV-AI and negative total-IgG OCB,
herpes simplex blisters in the area innervated by the sec-
ond branch of the trigeminal nerve were present and the
patient developed facial nerve palsy; the result was con-
firmed in a second CSF/serum samples obtained 8 days
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also available in a case of neuroborreliosis (Table 1). All
of these cases were associated with CSF pleocytosis.
Other clinical diagnoses associated with positive viral
AIs as provided by the senders included “encephalitis”,
“meningitis”, “abducens and facial nerve paresis“, and
“clinically possible multiple sclerosis”; one VZV-AI posi-
tive patient was treated with tacrolimus (FK506), a po-
tent immunosuppressant, at the time of LP (Table 1).
To assess the plausibility of the negative total-IgG
OCB results, we analysed each patients’ total-IgG CSF/
serum ratio (QIgG). Elevated QIgG in the absence of
total-IgG OCB positivity would suggest a false-negative
OCB result. However, QIgG was found to be normal in
all patients (i.e. QIgG<Qlim) as shown in Figure 1.
Discussion
These cases confirm that negative total-IgG OCBs in
CSF samples might not always predict the absence of
positive virus- or bacterium-specific IgG-AIs in patients
with suspected CNS infection. Omitting AI testing in
OCB negative patients might thus be a possibleFigure 1 CSF/serum quotient diagram for IgG (‘Reibergram’).
Individual CSF/serum ratios of IgG (QIgG) were plotted against CSF/
serum albumin ratios (QAlb). Values above the upper hyperbolic
discrimination line Qlim indicate intrathecal total-IgG synthesis.
Individual intrathecal fractions, IgIF, can be obtained by interpolation
from the percentiles above Qlim. The Reibergram plot indicated that
there was no intrathecal total-IgG synthesis in the patients tested
here, confirming the negative OCB results. IgG = immunoglobulin G;
QIgG=CSF/serum total-IgG ratio; QAlb=CSF/serum albumin ratio.
Graph created using CSF Research Tool, Comed, Germany. Open
squares: Borrelia burgdorferi, Bb; upward triangles: varicella zoster virus,
VZV; open circles: herpes simplex virus, HSV; filled circles:
cytomegalovirus, CMV; filled squares: measles virus, MV; downward
triangles: rubella virus, RV.diagnostic pitfall. In addition to VZV infection [2], posi-
tive AIs have previously also been reported in individual
total-IgG OCB-negative patients with autoimmune dis-
orders of the central nervous system including anti-
GAD antibody positive stiff person syndrome [4], anti-Ri
positive paraneoplastic neurological syndromes (PNS)
[5], anti-CV2/CRMP5 positive PNS [6], and anti-Yo
positive PNS [3].
Around 2-5 % of patients with MS are negative for
OCBs. This subgroup, which is small in relative numbers
but not so small in absolute numbers due to the high
prevalence of MS, is particularly challenging from a
diagnostic point of view. A higher sensitivity of antigen-
specific AI calculation compared to total-IgG OCB test-
ing might therefore also be of potential relevance for the
laboratory diagnosis of multiple sclerosis (MS), since a
majority of patients with MS display a polyspecific
humoral antibody response to a broad variety of viral
and bacterial antigens as determined by AI calculation,
with intrathecal antibodies to MV, RV and VZV as its
most common constituents (termed MRZ reaction or
MRZR), as demonstrated by Reiber and others [7-9].
Apart from MS, a positive MRZR reaction has also been
reported in rare cases of lupus and CNS involvement
[7]. MRZR testing is currently performed by many CSF
laboratories in Germany, but, in our experience, is so far
almost exclusively done in OCB-positive patients. In line
with the hypothesis that tests for antigen-specific IgG
synthesis might be more sensitive than total-IgG OCB
detection, Stich et al. recently reported on positive AIs
for MV, RV, and VZV in 2/17 (12 %) total-IgG OCB-
negative patients with MS but in none of 11 controls.
Similarly, the authors found MV-, RV-, and VZV-
specific bands in 3/17 (18 %) total-IgG OCB-negative
patients with MS as detected by affinity blotting using
recombinant viral antigens and a highly sensitive chemi-
luminescence detection technique [8]. This is in accord-
ance with a report by Frederiksen and Sindic (1998),
who found CSF-restricted VZV- and mumps-specific
bands in total-IgG OCB-negative patients with MS using
a similar type of assay [9].
On the other hand, the fact that a subset of
patients with MS presents with a monospecific AI
elevation rather than the typical polyspecific, oligoclo-
nal reaction, at least at first presentation [10], and
that the spectrum of positive AIs can be broader than
just MV, RV, and VZV and include (though less fre-
quently) positive AIs for Bb, toxoplasma and other
viral and bacterial agents can pose differential diag-
nostic challenges in some cases. Accordingly, in
patients in whom MS is a reasonable differential diag-
nosis, AIs for at least the three main constituents of
the MRZ reaction (MV, RV, and VZV) should be
determined (approximate costs in Germany, ~20-30
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boratory results in general – must always be inter-
preted in the context of the patient’s overall clinical
and neuroradiological presentation and the patient’s
CSF findings such as white cell count and differenti-
ation, CSF/serum total-IgM ratios or total-IgA ratios
before a definite diagnosis can be made [1,11]. Bb-
IgM assessment can be useful in patients with sus-
pected acute Bb infection; however, it was negative in
6/6 patients in our study (not determined in one).
The reason for the higher sensitivity of AI detection
compared to total-IgG detection in the patients
reported here is unknown. Infections are often asso-
ciated with severe blood-CSF barrier dysfunction; the
presence of OCB may become undetectable in those
cases because of a relative increase of the blood-
derived polyclonal IgG fraction. In such cases OCBs
may possibly become positive after normalization of
barrier dysfunction. However, high CSF/serum albu-
min ratios were present only in a subset of our
patients (see Figure 1). Moreover, the higher sensitiv-
ity of antigen-specific OCBs compared to total-IgG
OCBs detection as demonstrated in a number of
studies [3-5] argues in favour of additional, so far un-
identified factors specific for total-IgG OCB detection
rather than OCB detection in general.
Possibly, AIs might become positive earlier than total-
IgG OCBs. If so, AI assessment might be particularly
useful at disease onset. However, as OCBs remained
negative in the few patients with follow-up LPs in our
study, our study provides no direct evidence for this
hypothesis.
There are some caveats. First, as it is the case with
IgG responses in general, there might be a delay in AIs
becoming positive as indicated by case 1 in Table 1; this
patients became positive for HSV only at lumbar punc-
tures (LP) #2 and LP #3. However, similar problems
apply to HSV PCR, which is sometimes negative at first
LP and becomes positive only with time. Therefore, re-
peat LP is recommended if the initial LP is negative. Sec-
ond, an expansion of the polyspecific, intrathecal
immune response in MS over time has been described
[10]. Accordingly, repeat LP might possibly be useful
also in individual patients with suspected MS but miss-
ing MRZR reaction at first LP. Third, cross-reactivity be-
tween VZV and HSV is a well-known phenomenon.
However, the true-positive AI generally yields higher
values, which usually allows identifying the relevant
agent (see patient 1, LP #3). It is therefore recommended
to test always for both VZV-AI and HSV-AI. Third, the
21 cases presented here were collected over a period of
9 years, suggesting that the phenomenon is relatively
rare; however, it is potentially of high relevance for the
individual patient.In summary, the cases reported here indicate that AI
testing should not generally be omitted in total-IgG
OCB-negative patients and provides a rationale for sys-
tematic and prospective studies on the comparative sen-
sitivity and specificity of AI and total-IgG OCB testing
in infectious diseases of the CNS as well as in other
indications.
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